PG-018

N/A

Report date: 2023/07/18 13:41:04
NME

Base Information

Drug NamePG-018
Drug Alias NamePG-018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK1
Therapy Area/IndicationsNephrosisGlomerulonephritis, Membranous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPrime Gene Therapeutics Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPrime Gene Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsNephrosisGlomerulonephritis, Membranous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A